Know Cancer

or
forgot password

Pathway to Diagnosis of Ovarian Cancer: Observational Retrospective Multicenter Study


Phase 3
18 Years
N/A
Open (Enrolling)
Female
Ovarian Cancer

Thank you

Trial Information

Pathway to Diagnosis of Ovarian Cancer: Observational Retrospective Multicenter Study


Inclusion Criteria:



- Histological diagnosis of ovarian cancer

- Indication for chemotherapy

- Age > 18 years

- Signed informed consent

Exclusion Criteria:

- Previous chemotherapy

- Unable or unwilling to participate in interview

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Retrospective

Outcome Measure:

the frequency and duration of symptoms in 12 months preceding ovarian cancer diagnosis

Outcome Time Frame:

at baseline

Safety Issue:

No

Principal Investigator

Sandro Pignata, M.D., Ph.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

National Cancer Institute, Naples

Authority:

Italy: Ethics Committee

Study ID:

MITO 12

NCT ID:

NCT01061619

Start Date:

January 2010

Completion Date:

July 2013

Related Keywords:

  • Ovarian Cancer
  • prediagnostic symptoms
  • sentinel events
  • pathway to diagnosis
  • Ovarian Neoplasms

Name

Location